Transplant anti-rejection drugs and risk of melanoma Print
UPI: Organ transplant patients are twice as likely as people without transplants to develop melanoma and 3 times as likely to die from it, according to a new study. Researchers found that patients were more likely to develop melanoma within the first 4 years of taking immunosuppressive drugs meant to keep their bodies from rejecting transplanted organs. Previously, scientists thought the potential for the drugs to influence cancer development would come after many years of taking the drugs.

...